Home
Conditions
Proteostasis Deficiencies

Clinical trial condition

Proteostasis Deficiencies

Explore clinical trials studying Proteostasis Deficiencies. Study availability and eligibility vary by location and protocol.

1,351 public trials 352 recruiting studies

Refine in advanced search Browse all conditions

Proteostasis Deficiencies trial results

Completed

Ocular Surface Metabolo-lipidomics in Lateral Amyotrophic Sclerosis

NCT04953286

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Lacerations, +10 more
Locations: Ophthalmology Department, University Hospital of Tours, France Tours, France

Neurology Department, University Hospital of Tours, France Tours, France

Centre d'Investigation Clinique_CIC 1415 Tours, France

View Trial Details

Completed

A Study of VRG50635 in Healthy Volunteers

NCT06286475

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Healthy Volunteers, +9 more
Locations: Lincoln Celerion Inc., Lincoln, Nebraska, United States

View Trial Details

Completed

Brain Hemorrhage and Functional Outcome in Stroke Patients With CAA Features on Pre-thrombolysis MRI Treated With Intravenous Thrombolysis (Thrombolysis in CAA) ( Thromb in CAA )

NCT05565144

Conditions: Amyloidosis, Brain Diseases, Cardiovascular Diseases, +14 more
Locations: CHU de Nîmes Nîmes, France

View Trial Details

Completed

A Phase 2 Study to Evaluate Safety of Long-term AL001 Dosing in Frontotemporal Dementia (FTD) Patients (INFRONT-2)

NCT03987295

Conditions: Brain Diseases, Central Nervous System Diseases, Dementia, +10 more
Locations: UCSF San Francisco, California, United States

Mayo Clinic Rochester, Minnesota, United States

University of Pennsylvania Philadelphia, Pennsylvania, United States

The Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases UT Health San Antonio San Antonio, Texas, United States

View Trial Details

Completed

Conservative Iron Chelation as a Disease-modifying Strategy in Amyotrophic Lateral Sclerosis

NCT03293069

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Chr Angers Angers, France

Chru Brest Brest, France

Hopital Pierre Wertheimer - Hcl - Bron Bron, France

Chu Cote de Nacre - Caen Caen, France

View all 15 locations

View Trial Details

Completed

Cardiac Amyloidosis Discovery Trial

NCT06469372

Conditions: Amyloid Neuropathies, Amyloid Neuropathies, Familial, Amyloidosis, +13 more
Locations: Columbia University Irving Medical Center / NewYork-Presbyterian Hospital New York, United States

View Trial Details

Completed

Cerebellar Superficial Siderosis in Cerebral Amyloid Angiopathy

NCT05394636

Conditions: Amyloidosis, Brain Diseases, Cardiovascular Diseases, +17 more
Locations: CHU de Nîmes Nîmes, France

View Trial Details

Completed

Periventricular White Matter Hyperintensities in Cerebral Amyloid Angiopathy and Hypertensive Arteriopathy

NCT05486897

Conditions: Amyloidosis, Brain Diseases, Cardiovascular Diseases, +11 more
Locations: CHU de Nîmes Nîmes, France

View Trial Details

Completed

MIROCALS: Modifying Immune Response and OutComes in ALS

NCT03039673

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: CHRU de Lille - Hôpital Roger Salengro Lille, France

CHU de Limoges - Hôpital Dupuytren Limoges, France

HCL - Hôpital Neurologique P. Wertheimer Lyon, France

APHM - Hôpital de la Timone Marseille, France

View all 17 locations

View Trial Details

Completed

Comprehensive Biomarker Profiling of the IFN-α Pathway in Amyotrophic Lateral Sclerosis Patient Biofluids

NCT07260981

Conditions: ALS - Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, +9 more
Locations: Pioneer Life Sciences Cherrywood Dublin, Ireland

View Trial Details

Proteostasis Deficiencies

Proteostasis Deficiencies trial results

Related conditions